| UniProt ID | SBNO2_HUMAN | |
|---|---|---|
| UniProt AC | Q9Y2G9 | |
| Protein Name | Protein strawberry notch homolog 2 | |
| Gene Name | SBNO2 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 1366 | |
| Subcellular Localization | ||
| Protein Description | Acts as a transcriptional coregulator, that can have both coactivator and corepressor functions. Inhibits the DCSTAMP-repressive activity of TAL1, hence enhancing the access of the transcription factor MITF to the DC-STAMP promoter in osteoclast. Plays a role in bone homeostasis; required as a positive regulator in TNFSF11//RANKL-mediated osteoclast fusion via a DCSTAMP-dependent pathway. May also be required in the regulation of osteoblast differentiation (By similarity). Involved in the transcriptional corepression of NF-kappaB in macrophages. [PubMed: 18025162 Plays a role as a regulator in the proinflammatory cascade] | |
| Protein Sequence | MLAVGPAMDRDYPQHEPPPAGSLLYSPPPLQSAMLHCPYWNTFSLPPYPAFSSDSRPFMSSASFLGSQPCPDTSYAPVATASSLPPKTCDFAQDSSYFEDFSNISIFSSSVDSLSDIVDTPDFLPADSLNQVSTIWDDNPAPSTHDKLFQLSRPFAGFEDFLPSHSTPLLVSYQEQSVQSQPEEEDEAEEEEAEELGHTETYADYVPSKSKIGKQHPDRVVETSTLSSVPPPDITYTLALPSDSGALSALQLEAITYACQQHEVLLPSGQRAGFLIGDGAGVGKGRTVAGVILENHLRGRKKALWFSVSNDLKYDAERDLRDIEATGIAVHALSKIKYGDTTTSEGVLFATYSALIGESQAGGQHRTRLRQILDWCGEAFEGVIVFDECHKAKNAGSTKMGKAVLDLQNKLPLARVVYASATGASEPRNMIYMSRLGIWGEGTPFRNFEEFLHAIEKRGVGAMEIVAMDMKVSGMYIARQLSFSGVTFRIEEIPLAPAFECVYNRAALLWAEALNVFQQAADWIGLESRKSLWGQFWSAHQRFFKYLCIAAKVRRLVELAREELARDKCVVIGLQSTGEARTREVLGENDGHLNCFVSAAEGVFLSLIQKHFPSTKRKRDRGAGSKRKRRPRGRGAKAPRLACETAGVIRISDDSSTESDPGLDSDFNSSPESLVDDDVVIVDAVGLPSDDRGPLCLLQRDPHGPGVLERVERLKQDLLDKVRRLGRELPVNTLDELIDQLGGPQRVAEMTGRKGRVVSRPDGTVAFESRAEQGLSIDHVNLREKQRFMSGEKLVAIISEASSSGVSLQADRRVQNQRRRVHMTLELPWSADRAIQQFGRTHRSNQVSAPEYVFLISELAGERRFASIVAKRLESLGALTHGDRRATESRDLSKYNFENKYGTRALHCVLTTILSQTENKVPVPQGYPGGVPTFFRDMKQGLLSVGIGGRESRNGCLDVEKDCSITKFLNRILGLEVHKQNALFQYFSDTFDHLIEMDKREGKYDMGILDLAPGIEEIYEESQQVFLAPGHPQDGQVVFYKISVDRGLKWEDAFAKSLALTGPYDGFYLSYKVRGNKPSCLLAEQNRGQFFTVYKPNIGRQSQLEALDSLRRKFHRVTAEEAKEPWESGYALSLTHCSHSAWNRHCRLAQEGKDCLQGLRLRHHYMLCGALLRVWGRIAAVMADVSSSSYLQIVRLKTKDRKKQVGIKIPEGCVRRVLQELRLMDADVKRRQAPALGCPAPPAPRPLALPCGPGEVLDLTYSPPAEAFPPPPHFSFPAPLSLDAGPGVVPLGTPDAQADPAALAHQGCDINFKEVLEDMLRSLHAGPPSEGALGEGAGAGGAAGGGPERQSVIQFSPPFPGAQAPL | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 227 | Ubiquitination | VVETSTLSSVPPPDI EEEECCCCCCCCCCC | 29.40 | 24816145 | |
| 278 | Ubiquitination | RAGFLIGDGAGVGKG CEEEEECCCCCCCCC | 36.45 | 29967540 | |
| 284 | Acetylation | GDGAGVGKGRTVAGV CCCCCCCCCCCCHHH | 42.70 | 7959451 | |
| 284 | Ubiquitination | GDGAGVGKGRTVAGV CCCCCCCCCCCCHHH | 42.70 | 24816145 | |
| 287 | Phosphorylation | AGVGKGRTVAGVILE CCCCCCCCCHHHHHH | 24.31 | - | |
| 307 | Phosphorylation | RKKALWFSVSNDLKY CCCEEEEECCCCCCC | 17.04 | 20873877 | |
| 309 | Phosphorylation | KALWFSVSNDLKYDA CEEEEECCCCCCCCH | 24.35 | 20873877 | |
| 335 | Ubiquitination | IAVHALSKIKYGDTT HHHHHHHCCCCCCCC | 44.03 | 29967540 | |
| 337 | Ubiquitination | VHALSKIKYGDTTTS HHHHHCCCCCCCCCC | 47.09 | - | |
| 410 | Ubiquitination | AVLDLQNKLPLARVV HHHHHHHHCCCEEHH | 38.22 | - | |
| 457 | Ubiquitination | EFLHAIEKRGVGAME HHHHHHHHCCCCCEE | 48.62 | - | |
| 476 | Phosphorylation | DMKVSGMYIARQLSF CEECCCEEEEEEEEE | 8.58 | - | |
| 568 | Trimethylation | REELARDKCVVIGLQ HHHHHHCCEEEEECC | 24.31 | - | |
| 568 | Methylation | REELARDKCVVIGLQ HHHHHHCCEEEEECC | 24.31 | - | |
| 577 | Phosphorylation | VVIGLQSTGEARTRE EEEECCCCCCCHHHH | 26.53 | 23403867 | |
| 582 | Phosphorylation | QSTGEARTREVLGEN CCCCCCHHHHHHCCC | 37.92 | 23403867 | |
| 615 | Phosphorylation | IQKHFPSTKRKRDRG HHHHCCCCCCCCCCC | 34.80 | - | |
| 658 | Ubiquitination | ISDDSSTESDPGLDS ECCCCCCCCCCCCCC | 55.91 | 29967540 | |
| 664 | Ubiquitination | TESDPGLDSDFNSSP CCCCCCCCCCCCCCH | 52.67 | 29967540 | |
| 715 | Ubiquitination | LERVERLKQDLLDKV HHHHHHHHHHHHHHH | 48.24 | 29967540 | |
| 721 | Ubiquitination | LKQDLLDKVRRLGRE HHHHHHHHHHHHCCC | 37.30 | 29967540 | |
| 733 | Phosphorylation | GRELPVNTLDELIDQ CCCCCCCCHHHHHHH | 35.50 | 22210691 | |
| 799 | Phosphorylation | EKLVAIISEASSSGV CCEEEHHHHHHCCCC | 22.46 | 21406692 | |
| 802 | Phosphorylation | VAIISEASSSGVSLQ EEHHHHHHCCCCCHH | 22.45 | 21406692 | |
| 803 | Phosphorylation | AIISEASSSGVSLQA EHHHHHHCCCCCHHH | 37.85 | 21406692 | |
| 804 | Phosphorylation | IISEASSSGVSLQAD HHHHHHCCCCCHHHH | 40.49 | 21406692 | |
| 807 | Phosphorylation | EASSSGVSLQADRRV HHHCCCCCHHHHHHH | 20.49 | 20068231 | |
| 837 | Ubiquitination | SADRAIQQFGRTHRS CHHHHHHHHCCCCCC | 36.33 | 29967540 | |
| 844 | Phosphorylation | QFGRTHRSNQVSAPE HHCCCCCCCCCCCCC | 24.82 | 25278378 | |
| 848 | Phosphorylation | THRSNQVSAPEYVFL CCCCCCCCCCCCHHH | 28.48 | 25278378 | |
| 852 | Phosphorylation | NQVSAPEYVFLISEL CCCCCCCCHHHHHHH | 8.74 | 24719451 | |
| 857 | Phosphorylation | PEYVFLISELAGERR CCCHHHHHHHHCCHH | 28.80 | 24719451 | |
| 871 | Acetylation | RFASIVAKRLESLGA HHHHHHHHHHHHCCC | 46.77 | 25953088 | |
| 871 | Ubiquitination | RFASIVAKRLESLGA HHHHHHHHHHHHCCC | 46.77 | - | |
| 875 | Phosphorylation | IVAKRLESLGALTHG HHHHHHHHCCCCCCC | 36.37 | - | |
| 894 | Ubiquitination | TESRDLSKYNFENKY CCCCCHHHHCCCCCC | 52.06 | 29967540 | |
| 900 | Ubiquitination | SKYNFENKYGTRALH HHHCCCCCCHHHHHH | 37.55 | - | |
| 939 | Ubiquitination | PTFFRDMKQGLLSVG CCHHHHHHCCCCCCC | 45.57 | - | |
| 939 | Sumoylation | PTFFRDMKQGLLSVG CCHHHHHHCCCCCCC | 45.57 | - | |
| 939 | Sumoylation | PTFFRDMKQGLLSVG CCHHHHHHCCCCCCC | 45.57 | - | |
| 961 | Ubiquitination | NGCLDVEKDCSITKF CCCCCCCCCCHHHHH | 64.98 | - | |
| 967 | Ubiquitination | EKDCSITKFLNRILG CCCCHHHHHHHHHHC | 46.30 | - | |
| 992 | Ubiquitination | QYFSDTFDHLIEMDK HHHHHHHHHHHHHHH | 37.46 | 29967540 | |
| 1049 | Ubiquitination | ISVDRGLKWEDAFAK EEECCCCCHHHHHHH | 51.89 | 29967540 | |
| 1064 | Phosphorylation | SLALTGPYDGFYLSY HHHHHCCCCCEEEEE | 30.00 | 25884760 | |
| 1068 | Phosphorylation | TGPYDGFYLSYKVRG HCCCCCEEEEEEEEC | 10.56 | 25884760 | |
| 1071 | Phosphorylation | YDGFYLSYKVRGNKP CCCEEEEEEEECCCC | 15.77 | 25884760 | |
| 1072 | Sumoylation | DGFYLSYKVRGNKPS CCEEEEEEEECCCCC | 23.29 | - | |
| 1072 | Sumoylation | DGFYLSYKVRGNKPS CCEEEEEEEECCCCC | 23.29 | - | |
| 1095 | Ubiquitination | GQFFTVYKPNIGRQS CCEEEEECCCCCCHH | 27.53 | - | |
| 1153 | Ubiquitination | CRLAQEGKDCLQGLR HHHHHHCCHHHHHHH | 44.51 | - | |
| 1165 | Phosphorylation | GLRLRHHYMLCGALL HHHHHHHHHHHHHHH | 5.90 | - | |
| 1172 | Ubiquitination | YMLCGALLRVWGRIA HHHHHHHHHHHHHHH | 4.04 | 29967540 | |
| 1189 | Phosphorylation | MADVSSSSYLQIVRL HCCCCCCHHEEEEEE | 31.63 | - | |
| 1198 | Phosphorylation | LQIVRLKTKDRKKQV EEEEEEECCCCCHHC | 42.65 | - | |
| 1229 | Ubiquitination | RLMDADVKRRQAPAL HCCCCCCCCCCCCHH | 42.27 | 29967540 | |
| 1229 | Acetylation | RLMDADVKRRQAPAL HCCCCCCCCCCCCHH | 42.27 | 25953088 | |
| 1329 | Phosphorylation | SLHAGPPSEGALGEG HHHCCCCCCCCCCCC | 52.36 | 28555341 | |
| 1356 | Phosphorylation | RQSVIQFSPPFPGAQ CCCEEECCCCCCCCC | 18.45 | 27251275 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of SBNO2_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of SBNO2_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of SBNO2_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
Oops, there are no PPI records of SBNO2_HUMAN !! | ||||
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...